IndraLab

Statements



reach
"In support of the role of autophagy in modulating response to treatment, the administration of hydroxychloroquine (HCQ), an autophagy inhibitor, was found to enhance anti-cancer activity of the histone deacetylase inhibitor, vorinostat (VOR), in preclinical models and early phase clinical studies of metastatic CRC [XREF_BIBR]."
| PMC

reach
"Preclinical models showed that HCQ enhances the antineoplastic activity of vorinostat (VOR) in colorectal cancer (CRC) cells [18]."

reach
"For example, HCQ has been reported to enhance the anti-cancer activity of the histone deacetylase inhibitor, vorinostat (VOR), in pre-clinical models and early phase clinical studies of metastatic colorectal cancer (mCRC) [75]."

reach
"Hydroxychloroquine (HCQ) enhances the anti-cancer activity of the histone deacetylase inhibitor, vorinostat (VOR), in pre-clinical models and early phase clinical studies of metastatic colorectal cancer (mCRC)."

reach
"It has been hypothesized that hydroxychloroquine could potentiate the activity of vorinostat through inhibition of autophagy, and this combination has been evaluated for safety in the oncology setting [XREF_BIBR]."

reach
"For example, HCQ has been reported to enhance the anticancer activity of the histone deacetylase inhibitor, vorinostat (VOR), in pre-clinical models and early phase clinical studies of metastatic colorectal cancer (mCRC) (Patel et al., 2016)."
| DOI